ID BHP 10-3 AC CVCL_6278 SY BHP10-3; BHP-10 DR BioSample; SAMN03151969 DR Cosmic; 1005449 DR Cosmic; 1094767 DR Wikidata; Q54796447 RX PubMed=9253346; RX PubMed=18713817; RX PubMed=20143388; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388). CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00179. CC Population: Japanese. CC Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68fs (c.204_208delGGAGC); Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln1089Ter (c.3265C>T); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line). CC Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046. ST Source(s): PubMed=18713817 ST Amelogenin: X ST D13S317: 11,12 ST D18S51: 13,16 ST D21S11: 30,31.2 ST D3S1358: 16,17 ST D5S818: 8,10 ST D7S820: 11 ST D8S1179: 11,17 ST FGA: 20,21 ST vWA: 14,18 DI NCIt; C4035; Thyroid gland papillary carcinoma DI ORDO; Orphanet_146; Differentiated thyroid carcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_6298 ! TPC-1 SX Female AG Adult CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 27 // RX PubMed=20143388; DOI=10.1002/ijc.25242; RA Capes-Davis, Amanda RA Theodosopoulos, George RA Atkin, Isobel RA Drexler, Hans Gunther RA Kohara, Arihiro RA MacLeod, Roderick A.F. RA Masters, John R.W. RA Nakamura, Yukio RA Reid, Yvonne A. RA Reddel, Roger Robert RA Freshney, Robert Ian RT "Check your cultures! A list of cross-contaminated or misidentified RT cell lines."; RL Int. J. Cancer 127:1-8(2010). // RX PubMed=9253346; DOI=10.1210/jcem.82.8.4136; RA Ohta, Kazuyasu RA Pang, Xuan-Ping RA Berg, Loretta RA Hershman, Jerome Marshall RT "Growth inhibition of new human thyroid carcinoma cell lines by RT activation of adenylate cyclase through the beta-adrenergic RT receptor."; RL J. Clin. Endocrinol. Metab. 82:2633-2638(1997). // RX PubMed=18713817; DOI=10.1210/jc.2008-1102; PMCID=PMC2582569; RA Schweppe, Rebecca E. RA Klopper, Joshua Paul RA Korch, Christopher T. RA Pugazhenthi, Umarani RA Benezra, Miriam RA Knauf, Jeffrey A. RA Fagin, James Alexander RA Marlow, Laura A. RA Copland, John Alton 3rd RA Smallridge, Robert Christian RA Haugen, Bryan R. RT "Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer RT cell lines reveals cross-contamination resulting in cell line RT redundancy and misidentification."; RL J. Clin. Endocrinol. Metab. 93:4331-4341(2008). //